William Hildebrand to Antigens, Neoplasm
This is a "connection" page, showing publications William Hildebrand has written about Antigens, Neoplasm.
Connection Strength
1.032
-
A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer. Oncoimmunology. 2020; 9(1):1685300.
Score: 0.630
-
Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens. Proc Natl Acad Sci U S A. 2019 11 19; 116(47):23662-23670.
Score: 0.157
-
Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 May 15; 348(6236):803-8.
Score: 0.114
-
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol. 2006 Oct 15; 177(8):5088-97.
Score: 0.063
-
Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors. J Immunother Cancer. 2022 Oct; 10(10).
Score: 0.048
-
Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Cancer Immunol Immunother. 2010 Apr; 59(4):563-73.
Score: 0.019